Urological research group – UroReg Urological register and biobank
Group leader
The primary aim of the research group is to establish a patient registry and biobank for urological patients, with a particular focus on endourology, urothelial carcinoma (bladder, ureteral and urethral cancer), kidney cancer, and benign prostatic hyperplasia (BPH). The long‑term objective is to use these data to identify prognostic and predictive factors that may contribute to improved patient selection, treatment strategies and clinical outcomes. The research group will collaborate with relevant national and international expert groups.
Group leader: Andreas Hanssønn Habberstad, Urologist, PhD